Prospettive Sociali e Sanitarie

Clinical Features of Bipolar Depression Versus Major Depressive Disorder in Large Multicenter Trials 225-231
Gabriele S. Leverich, Lori L. Altshuler, Mark A. Frye, Trisha Suppes, Susan L. McElroy, Paul E. Keck, Jr., Ralph W.
Kupka, Kirk D. Denicoff, Willem A. Nolen, Heinz Grunze, Maria I. Martinez, and Robert M. Post
Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and
Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers 232-239
Ping-I Lin, Melvin G. McInnis, James B. Potash, Virginia Willour, Dean F. MacKinnon, J. Raymond DePaulo, and
Peter P. Zandi
Clinical Correlates and Familial Aggregation of Age at Onset in Bipolar Disorder 240-246
Mauricio Tohen, Joseph R. Calabrese, Gary S. Sachs, Michael D. Banov, Holland C. Detke, Richard Risser, Robert W.
Baker, James C.-Y. Chou, and Charles L. Bowden
Randomized, Placebo-Controlled Trial of Olanzapine as Maintenance Therapy in Patients With Bipolar I Disorder
Responding to Acute Treatment With Olanzapine 247-256
Stephanie Krüger, Martin Alda, L. Trevor Young, Kim Goldapple, Saghar Parikh, and Helen S. Mayberg
Risk and Resilience Markers in Bipolar Disorder: Brain Responses to Emotional Challenge in Bipolar Patients and
Their Healthy Siblings 257-264
Dina R. Hirshfeld-Becker, Joseph Biederman, Aude Henin, Stephen V. Faraone, Gabrielle A. Cayton, and Jerrold F.
Rosenbaum
Laboratory-Observed Behavioral Disinhibition in the Young Offspring of Parents With Bipolar Disorder: A High-Risk
Pilot Study 265-271
Michael H. Allen, Robert M. Hirschfeld, Patricia J. Wozniak, Jeffrey D. Baker, Ph.D., and Charles L. Bowden
Linear Relationship of Valproate Serum Concentration to Response and Optimal Serum Levels for Acute Mania 272-
275
Jaeuk Hwang, In Kyoon Lyoo, Stephen R. Dager, Seth D. Friedman, Jung Su Oh, Jun Young Lee, Seog Ju Kim, David
L. Dunner, and Perry F. Renshaw
Basal Ganglia Shape Alterations in Bipolar Disorder 276-285
Mani N. Pavuluri, Lindsay S. Schenkel, Subhash Aryal, Erin M. Harral, S. Kristian Hill, Ellen S. Herbener, and John A.
Sweeney
Neurocognitive Function in Unmedicated Manic and Medicated Euthymic Pediatric Bipolar Patients 286-293
John N. Constantino, Clara Lajonchere, Marin Lutz, Teddi Gray, Anna Abbacchi, Kathleen McKenna, Deepti Singh,
and Richard D. Todd
Autistic Social Impairment in the Siblings of Children With Pervasive Developmental Disorders 294-296
Wendy S. Slutske
Natural Recovery and Treatment-Seeking in Pathological Gambling: Results of Two U.S. National Surveys 297-302
Jon E. Grant, Marc N. Potenza, Eric Hollander, Renee Cunningham-Williams, Tommi Nurminen, Gerard Smits, and
Antero Kallio
Multicenter Investigation of the Opioid Antagonist Nalmefene in the Treatment of Pathological Gambling 303-312
Brief Reports:
Lori L. Altshuler, Trisha Suppes, David O. Black, Willem A. Nolen, Gabriele Leverich, Paul E. Keck, Jr., Mark A.
Frye, Ralph Kupka, Susan L. McElroy, Heinz Grunze, Christina M.R. Kitchen, and Robert Post
Lower Switch Rate in Depressed Patients With Bipolar II Than Bipolar I Disorder Treated Adjunctively With Second-
Generation Antidepressants 313-315
Constance M. Moore, Joseph Biederman, Janet Wozniak, Eric Mick, Megan Aleardi, Megan Wardrop, Meghan
Dougherty, Terri Harpold, Paul Hammerness, Edin Randall, and Perry F. Renshaw
Differences in Brain Chemistry in Children and Adolescents With Attention Deficit Hyperactivity Disorder With and
Without Comorbid Bipolar Disorder: A Proton Magnetic Resonance Spectroscopy Study 316-318
Benjamin I. Goldstein, Nathan Herrmann, and Kenneth I. Shulman
Comorbidity in Bipolar Disorder Among the Elderly: Results From an Epidemiological Community Sample 319-321